Year: 2023

BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection Fraction

SUNNYVALE, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a developer of cellular and cell-derived therapeutics for the treatment...

Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States

BERWYN, Pa.--(BUSINESS WIRE)--Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today the completion of its...

FamGenix and Spesana Announce Strategic Partnership to Advance Patient Care Workflow Solutions & Integrate Hereditary Risk Screening

DELRAY BEACH, Fla. & MEMPHIS, Tenn.--(BUSINESS WIRE)--FamGenix and Spesana, two leading health-tech companies, are thrilled to announce a strategic partnership...

error: Content is protected !!